Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04730609
PHASE4

Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.

Official title: Dexmedetomidine for Treatment of Shivering During Scheduled Elective Cesarean Delivery: Determining the Optimal Dose

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2021-09-21

Completion Date

2026-08

Last Updated

2025-09-11

Healthy Volunteers

No

Interventions

DRUG

Dexmedetomidine

Doses of dexmedetomidine will be selected according to a sequential up-and-down method, using a biased coin design to find the estimated dose at which 90% of patients would have desired effect

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States